Reversible epstein-barr virus associated t cell nonhodgkin's lymphoma in a patient with rheumatoid arthritis undergoing chronic immunosuppressive therapy

Journal of Rheumatology

Volumn 25, Issue 2, 1998, Pages 389-391

  Vassilopoulos, Dimitrios ^a   Waltuck, Jonathan ^a   Clarke, Gwendolyn ^a   Farhi, Diane C ^a   Williams, Jeff ^a   Fanucchi, Michael P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; LEUKOCYTE ANTIGEN; MATRIX PROTEIN;

CASE REPORT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LETTER; METABOLISM; MIDDLE AGED; RHEUMATOID ARTHRITIS; T CELL LYMPHOMA; VIROLOGY;

ANTIGENS, CD; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; LYMPHOMA, T-CELL; MIDDLE AGED; VIRAL MATRIX PROTEINS;

EID: 0031989598     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nalesnik MA. Posttransplantation lymphoproliferative disorders: Current perspectives. Semin Thorac Cardiovasc Surg 1996:8:139-48.
2. Knowles DM, Chamulak GA. Subar M. et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome. The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 1988; 108:744-53.
3. Biemer JJ. Malignant lymphomas associated with immunodeficiency states. Ann Clin Lab Sci 1990;20:175-91.
4. Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985:78:44-9.
5. Hakulinen T. Isomaki H. Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med 1985:78:29-32.
6. Prior P. Cancer and rheumatoid arthritis: Epidemiologie considerations. Am J Med 1985:78:15-21.
7. Silman AJ, Pétrie J. Hazleman B, et al. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: A 20 year follow up study. Ann Rheum Dis 1988:47:988-92.
8. Kinlen LJ. Malignancy in autoimmune diseases. J Autoimmun 1992:5 SupplA:363-71.
9. Gridley G, McLaughlin JK. Ekbom A. et al. Incidence of cancer among patients with rheumatoid arthritis. J Nat Cancer Inst 1993:85:307-11.
10. Gridley G. Klippel JH. Hoover RN, et al. Incidence of cancer among men with the Felty syndrome. Ann Intern Med 1994:120:35-9.
11. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
12. Kamel OW, van de Rijn M, Hanasono MM, et al. Immunosuppression-associated lymphoproliferative disorders in rheumatic patients. Leukemia Lymphoma 1995:16:363-8.
13. Kamel OW, van de Rijn M, LeBrun DP, et al. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994:25:638-3.
14. van Gorp J, Doornewaard H, Verdonck LF, et al. Posttransplant T-cell lymphoma. Report of three cases and a review of the literature. Cancer 1994:73:3064-72.
15. Waller EK, Ziemianska M, Bangs CD, et al. Characterization of posttransplant lymphomas that express T-cell-associated markers: Immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice. Blood 1993:82:247-61.
16. Shiroky JB, Frost A, Skelton JD, et al. Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol 1991:18:1172-5.
17. Cobeta-Garcia JC, Ruiz-Jimeno MT, Fontova-Garrofe R. NonHodgkin's lymphoma, rheumatoid arthritis and methotrexate. J Rheumatol 1993:20:200-2.
18. Tsoukas CD, Lambris JD. Expression of EBV/C3d receptors on T cells: Biological significance. Immunol Today 1993:14:56-9.
19. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996:14:1943-9.